ArticleHNO2022

Efficacy and safety of systemic, high-dose glucocorticoid therapy for idiopathic sudden sensorineural hearing loss : Study protocol for a three-armed, randomized, triple-blind, multicenter trial (HODOKORT).

Stefan K Plontke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.